NASDAQ:CLDX - Nasdaq - US15117B2025 - Common Stock
TTM (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
---|---|---|---|---|---|---|---|---|
Revenue | 9.98M | 6.88M | 2.36M | 4.65M | 7.42M | |||
Operating Expenses | 184.15M | 148.93M | 102.59M | 72.39M | 52.77M | |||
Research and Development | 147.04M | 118.01M | 82.26M | 53.31M | 42.53M | |||
Selling, General, and Administrative Expenses | 37.12M | 30.91M | 27.20M | 20.49M | 14.46M | |||
Operating Income | -174.18M | -142.04M | -100.23M | -67.74M | -45.35M | |||
Interest Income/Expense | 32.60M | 13.11M | 2.91M | 510.00K | 2.41M | |||
Non Recurring Items | N/A | -12.50M | -15.00M | -3.50M | -18.00M | |||
Income Before Taxes | -154.08M | -141.43M | -112.33M | -70.74M | -60.95M | |||
Income Tax | N/A | 0.00 | 0.00 | -230.00K | -1.17M | |||
Net Income | -154.08M | -141.43M | -112.33M | -70.51M | -59.78M | |||
EBITDA | -171.06M | -139.03M | -97.33M | -64.67M | -41.42M | |||
Per Share Data | ||||||||
EPS Diluted Total Ops | -2.57 | -2.92 | -2.40 | -1.64 | -2.02 | |||
Non GAAP EPS | -2.57 | -2.91 | -2.21 | -1.64 | -2.14 | |||
Statistics | ||||||||
Profit Margin | -1544.48% | -2054.76% | -4759.75% | -1516.34% | -805.66% | |||
Operating Profit Margin | -1745.97% | -2063.66% | -4247.03% | -1456.77% | -611.19% |
All data in USD